Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Annals of Hematology|March 6, 2026
Evolution of outcomes in autologous stem cell transplantation for hodgkin lymphoma over 2 decades at King Hussein cancer centerZaid Abdel Rahman, Abeer Yaseen, Anas Zayed, et al.
Hematology (Amsterdam, Netherlands)|June 18, 2025
Dose adjusted EPOCH-R is superior to RCHOP in frontline treatment of mediastinal large B cell lymphomaMohammad Ma'koseh, Abeer Yaseen, Nebras Abu Abed, et al.
Clinical Hematology International|October 17, 2024
Prophylactic Cranial Irradiation prior to HCT for Acute Lymphoblastic Leukemia: To Boost or Not To BoostKhalid Halahleh, Mohammad S Makoseh, Ayat M Taqash, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 26, 2025
Outcomes of Peripheral Blood Haploidentical Stem Cell Transplantation With Post-Transplant Cyclophosphamide and Earlier Initiation of ImmunosuppressionMohammad Ma'koseh, Zaid Abdel Rahman, Abeer Yaseen, et al.
Hematology (Amsterdam, Netherlands)|April 1, 2026
Survival and prognostic features of early-stage diffuse large B-cell lymphoma in older adultsMohammad Ma'koseh, Omar Shahin, Alaa Abufara, et al.
Frontiers in Transplantation|June 1, 2026
Outcomes of allogeneic hematopoietic cell transplantation in patients with carbapenem-resistant organisms infection: a propensity score-matched analysisAbeer Yaseen, Teeba Mubaydeen, Hazem Al-Qaraleh, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 30, 2022
Pembrolizumab for the Treatment of Relapsed and Refractory Classical Hodgkin Lymphoma After Autologous Transplant and in Transplant-Naïve PatientsKhalid Halahleh, Suhaib Al Sawajneh, Yacob Saleh, et al.
American Journal of Hematology|April 24, 2024
Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationYishan Ye, Myriam Labopin, Socié Gérard, et al.
JCO Global Oncology|July 9, 2026
Point-of-Care Manufacturing of Anti-CD19.1-Chimeric Antigen Receptor-T Cells Using CliniMACS Prodigy: Real-World Experience From JordanKhalid Halahleh, Ahmad Abu-Khader, Husam Abu-Jazar, et al.
Bone Marrow Transplantation|October 16, 2025
Impact of Wilms' tumor 1 gene (WT1) mutation on outcome of allogeneic hematopoietic-cell transplantation for acute myeloid leukemia: a retrospective multicenter cohort study from the ALWP/EBMT registryArnon Nagler, Jordi Esteve, Jacques-Emmanuel Galimard, et al.
Pageof 5